Total Payments
$1,986
2024 Payments
$800.99
Companies
22
Transactions
91
Medicare Patients
1,679
Medicare Billing
$417,629
Payment Breakdown by Category
Food & Beverage$1,862 (93.7%)
Education$124.60 (6.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,862 | 89 | 93.7% |
| Education | $124.60 | 2 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $366.95 | 18 | $0 (2024) |
| Amgen Inc. | $266.37 | 8 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $259.92 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $119.09 | 7 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $110.34 | 6 | $0 (2024) |
| Travere Therapeutics, Inc. | $108.87 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $100.23 | 5 | $0 (2024) |
| NxStage Medical, Inc. | $95.13 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $81.86 | 5 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $78.22 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $800.99 | 36 | Amgen Inc. ($239.41) |
| 2023 | $446.14 | 22 | Travere Therapeutics, Inc. ($77.50) |
| 2022 | $429.84 | 15 | Mallinckrodt Hospital Products Inc. ($143.80) |
| 2021 | $115.36 | 7 | AstraZeneca Pharmaceuticals LP ($32.97) |
| 2020 | $194.01 | 11 | Mallinckrodt Hospital Products Inc. ($45.58) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Nephrology | ||||||
| 12/11/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.26 | General |
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Nephrology | ||||||
| 10/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Immunology | ||||||
| 09/03/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEPHROLOGY | ||||||
| 08/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Obesity | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.15 | General |
| 07/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $1.96 | General |
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/05/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 558 | 1,292 | $466,962 | $137,491 |
| 2022 | 7 | 493 | 1,280 | $456,259 | $134,085 |
| 2021 | 8 | 493 | 1,215 | $413,184 | $127,323 |
| 2020 | 5 | 135 | 196 | $62,570 | $18,731 |
Total Patients
1,679
Total Services
3,983
Medicare Billing
$417,629
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 30 | 175 | $158,611 | $46,101 | 29.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 179 | 623 | $111,953 | $37,228 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 210 | $68,880 | $18,694 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 122 | 131 | $65,594 | $17,308 | 26.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 15 | 39 | $29,258 | $8,609 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $17,418 | $4,846 | 27.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 29 | 48 | $8,793 | $2,508 | 28.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 25 | $6,455 | $2,197 | 34.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 31 | 167 | $151,360 | $44,865 | 29.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 166 | 730 | $131,181 | $38,883 | 29.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 123 | 140 | $70,101 | $20,709 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 128 | $41,984 | $11,605 | 27.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 24 | 49 | $36,760 | $10,963 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $19,967 | $5,606 | 28.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 19 | $4,906 | $1,454 | 29.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 34 | 172 | $141,926 | $46,798 | 33.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 194 | 692 | $125,943 | $37,624 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 126 | 147 | $74,416 | $22,188 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 114 | $34,934 | $9,560 | 27.4% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 14 | 26 | $17,361 | $5,705 | 32.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $9,246 | $2,657 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 20 | $5,295 | $1,563 | 29.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 17 | 22 | $4,063 | $1,226 | 30.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 30 | 30 | $15,498 | $4,687 | 30.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 38 | 79 | $14,647 | $4,421 | 30.2% |
About Dr. Muhammad Owais Malik, MD
Dr. Muhammad Owais Malik, MD is a Nephrology healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1376910208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Owais Malik, MD has received a total of $1,986 in payments from pharmaceutical and medical device companies, with $800.99 received in 2024. These payments were reported across 91 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,862).
As a Medicare-enrolled provider, Malik has provided services to 1,679 Medicare beneficiaries, totaling 3,983 services with total Medicare billing of $417,629. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Johnson City, TN
- Active Since 08/26/2015
- Last Updated 09/14/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1376910208
Products in Payments
- FARXIGA (Drug) $253.65
- ACTHAR (Biological) $231.22
- TAVNEOS (Drug) $217.93
- Kerendia (Drug) $119.09
- Velphoro (Drug) $110.34
- LOKELMA (Drug) $97.66
- LIBERTY SELECT CYCLER (Device) $95.13
- RAYALDEE (Drug) $78.22
- TARPEYO (Drug) $74.43
- BENLYSTA (Biological) $65.73
- Fabhalta (Drug) $59.37
- KRYSTEXXA (Biological) $53.34
- INJECTAFER (Drug) $41.93
- Veltassa (Drug) $41.86
- JARDIANCE (Drug) $40.66
- JYNARQUE (Drug) $35.52
- ULTOMIRIS (Biological) $33.81
- TERLIVAZ (Drug) $28.70
- Parsabiv (Drug) $26.96
- Vafseo (Drug) $24.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Johnson City
Dr. Martin Tran, D.o, D.O
Nephrology — Payments: $8,595
Nephrology $8,595
Ms. Cynthia Marsh, Np, NP
Nephrology — Payments: $6,935
Nephrology $6,935
Samardia Missick, Md, MD
Nephrology — Payments: $4,822
Nephrology $4,822
Dr. Leslie Panus, M.d, M.D
Nephrology — Payments: $17.76
Nephrology $17.76
Dr. Stanley Vermillion, Md, MD
Nephrology — Payments: $15.70
Nephrology $15.70